Encainide

Revision as of 00:08, 27 June 2021 by Blsimpso (talk | contribs) (Created page with "==Administration== *Type: Class IC antiarrhythmic (sodium channel blocker) *Dosage Forms: Capsules (25mg or 35mg) *Routes of Administration: PO *Common Trade Names: Enkaid ==...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Administration

  • Type: Class IC antiarrhythmic (sodium channel blocker)
  • Dosage Forms: Capsules (25mg or 35mg)
  • Routes of Administration: PO
  • Common Trade Names: Enkaid

Adult Dosing

Sustained Ventricular Tachycardia

  • 25mg PO t.i.d
    • May be increased to 35mg PO t.i.d after 3-5 days

Pediatric Dosing

  • Safety and effectiveness in pediatrics not established

Special Populations

Pregnancy Rating

Lactation risk

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Contraindications

  • Allergy to class/drug
  • Preexisting 2nd or 3rd-degree AV block
  • Preexisting right bundle branch block w/ left hemiblock
  • Presence of cardiogenic shock

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References

Retrieved from "https://www.wikem.org/w/index.php?title=Encainide&oldid=308390"